Literature DB >> 31621100

Significant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy.

AnnaLynn M Williams1, Andrea M Baran1, Mahlon Schaffer1, Jocelyn Bushart1, Lynn Rich1, Jeremiah Moore1, Paul M Barr1, Clive S Zent1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31621100      PMCID： PMC7967863          DOI： 10.1002/ajh.25663

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Obesity in adult lymphoma survivors.

Authors:  Filipa Lynce; Marieta Pehlivanova; Joseph Catlett; Vera Malkovska
Journal:  Leuk Lymphoma       Date:  2011-10-24

2.  iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillermo Dighiero; Hartmut Döhner; Peter Hillmen; Michael Keating; Emili Montserrat; Nicholas Chiorazzi; Stephan Stilgenbauer; Kanti R Rai; John C Byrd; Barbara Eichhorst; Susan O'Brien; Tadeusz Robak; John F Seymour; Thomas J Kipps
Journal:  Blood       Date:  2018-03-14       Impact factor: 22.113

3.  Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study.

Authors:  Paolo Strati; Sameer A Parikh; Kari G Chaffee; Neil E Kay; Timothy G Call; Sara J Achenbach; James R Cerhan; Susan L Slager; Tait D Shanafelt
Journal:  Br J Haematol       Date:  2017-06-04       Impact factor: 6.998

4.  Changes in diet and lifestyle and long-term weight gain in women and men.

Authors:  Dariush Mozaffarian; Tao Hao; Eric B Rimm; Walter C Willett; Frank B Hu
Journal:  N Engl J Med       Date:  2011-06-23       Impact factor: 91.245

5.  Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.

Authors:  John C Byrd; Bonnie Harrington; Susan O'Brien; Jeffrey A Jones; Anna Schuh; Steve Devereux; Jorge Chaves; William G Wierda; Farrukh T Awan; Jennifer R Brown; Peter Hillmen; Deborah M Stephens; Paolo Ghia; Jacqueline C Barrientos; John M Pagel; Jennifer Woyach; Dave Johnson; Jane Huang; Xiaolin Wang; Allard Kaptein; Brian J Lannutti; Todd Covey; Maria Fardis; Jesse McGreivy; Ahmed Hamdy; Wayne Rothbaum; Raquel Izumi; Thomas G Diacovo; Amy J Johnson; Richard R Furman
Journal:  N Engl J Med       Date:  2015-12-07       Impact factor: 91.245

6.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

Authors:  Peter W F Wilson; Ralph B D'Agostino; Lisa Sullivan; Helen Parise; William B Kannel
Journal:  Arch Intern Med       Date:  2002-09-09
  6 in total
  1 in total

1.  Acalabrutinib in treatment-naive chronic lymphocytic leukemia.

Authors:  John C Byrd; Jennifer A Woyach; Richard R Furman; Peter Martin; Susan O'Brien; Jennifer R Brown; Deborah M Stephens; Jacqueline C Barrientos; Stephen Devereux; Peter Hillmen; John M Pagel; Ahmed Hamdy; Raquel Izumi; Priti Patel; Min Hui Wang; Nitin Jain; William G Wierda
Journal:  Blood       Date:  2021-06-17       Impact factor: 25.476
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.